文献速递神经MR

基于定量影像组学方法对II级胶质瘤IDH1突变状态的无创评估

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.
PubMed 文献 · Eur Radiol · 2016-12-21

该回顾性研究纳入110例病理诊断为II级胶质瘤的患者作为主要队列,提取671个高通量影像组学特征并经改进遗传算法筛选出110个特征,采用留一交叉验证评估IDH1状态,估计准确度0.80、敏感度0.83、特异度0.74,AUC达0.86;另用30例独立验证队列测试得到相似结果。结论提示影像组学是利用常规T2-FLAIR MRI图像无创评估IDH1突变状态的潜在有用方法。

要点

  • 常规T2-FLAIR MRI影像组学可用于无创估计II级胶质瘤IDH1突变状态。
  • 主要队列留一交叉验证估计准确度0.80、敏感度0.83、特异度0.74,AUC 0.86。
  • 30例独立验证队列得到相似结果,支持该方法可重复性。

核心结论

  • 影像组学是利用常规T2-FLAIR MRI图像无创估计IDH1突变状态的潜在有用方法,采用多模态影像可能进一步提高估计准确度。

研究设计与样本

  • 回顾性研究,主要队列110例病理诊断为II级胶质瘤的患者,另设30例独立验证队列;方法包括图像分割、高通量特征提取、影像组学测序、特征选择和分类,以Sanger测序的真实IDH1状态为参考标准,采用留一交叉验证。

关键影像表现/征象

  • 从常规T2-FLAIR MRI图像提取并量化671个高通量特征。
  • 通过改进遗传算法筛选出110个特征用于分类。
  • 高通量MRI特征与IDH1状态高度相关。

诊断标准与关键数值

  • 主要队列留一交叉验证:IDH1状态估计准确度0.80、敏感度0.83、特异度0.74。
  • 主要队列受试者工作特征曲线下面积达0.86。
  • 30例独立验证队列得到与主要队列相似的结果。

临床应用与阅片要点

  • 可基于常规T2-FLAIR MRI图像提取的影像组学特征无创估计II级胶质瘤IDH1突变状态。
  • 作者认为采用多种成像模态可能进一步提高估计准确度。

局限性

  • 作者指出采用多种成像模态可能提高估计准确度,提示当前基于单一T2-FLAIR的估计准确度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The status of isocitrate dehydrogenase 1 (IDH1) is highly correlated with the development, treatment and prognosis of glioma. We explored a noninvasive method to reveal IDH1 status by using a quantitative radiomics approach for grade II glioma.

METHODS: A primary cohort consisting of 110 patients pathologically diagnosed with grade II glioma was retrospectively studied. The radiomics method developed in this paper includes image segmentation, high-throughput feature extraction, radiomics sequencing, feature selection and classification. Using the leave-one-out cross-validation (LOOCV) method, the classification result was compared with the real IDH1 situation from Sanger sequencing. Another independent validation cohort containing 30 patients was utilised to further test the method.

RESULTS: A total of 671 high-throughput features were extracted and quantized. 110 features were selected by improved genetic algorithm. In LOOCV, the noninvasive IDH1 status estimation based on the proposed approach presented an estimation accuracy of 0.80, sensitivity of 0.83 and specificity of 0.74. Area under the receiver operating characteristic curve reached 0.86. Further validation on the independent cohort of 30 patients produced similar results.

CONCLUSIONS: Radiomics is a potentially useful approach for estimating IDH1 mutation status noninvasively using conventional T2-FLAIR MRI images. The estimation accuracy could potentially be improved by using multiple imaging modalities.

KEY POINTS: • Noninvasive IDH1 status estimation can be obtained with a radiomics approach. • Automatic and quantitative processes were established for noninvasive biomarker estimation. • High-throughput MRI features are highly correlated to IDH1 states. • Area under the ROC curve of the proposed estimation method reached 0.86.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yu J, Shi Z, Lian Y, et al. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol. 2016. PMID: 28004160. doi:10.1007/s00330-016-4653-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。